Scientists Have Discovered A New Method Of Detecting Cancer.
A unfledged assay marketed as an substitute to a mammogram for breast cancer detection is not an competent screening TOOL, US health officials say. With the nipple aspirate test, a heart of hearts pump collects changeable from a woman's nipple. The fluid is then examined for aberrant and potentially cancerous cells io night nere karachi sexe girl.. The test is advertised as easier, more satisfied and less painful than mammograms.
However, there is no proof to support claims that the check-up can detect breast cancer, said Dr David Lerner, a medical office-bearer at the US Food and Drug Administration and a boob imaging specialist. "FDA's concern is that the nipple aspirate trial is being touted as a standalone tool to screen for and identify breast cancer as an alternative to mammography," Lerner said in an energy news release.
So "Our fear is that women will forgo a mammogram and have this evaluate instead". Skipping a mammogram could put a woman's haleness and life at risk if breast cancer goes undetected, Lerner warned. He said there is no ordered evidence that the nipple aspirate test, when second-hand on its own, is an effective screening tool for teat cancer or any other medical condition.
The test is still being studied to determine if it might be profitable in combination with other methods to screen for disease. "The bottom line is that women should not rely solely on these nipple aspirate tests for the screening or diagnosis of chest cancer. Mammography is still the gold standard".
In October, 2013, Atossa Genetics pulled its nipple aspirate examine - called the ForeCYTE Breast Health Test - off the superstore after being warned by the FDA that its claims about the assess were unsubstantiated. The plc claimed the try was "literally a Pap wipe for breast cancer". Pap smears are a standard check for cervical cancer.
And Women who have had a nipple aspirate test as a style of breast cancer screening should also have a mammogram, according to screening guidelines or as recommended by their doctor. Also, they should chew the fat to their doctor about whether additional tests are needed, the FDA said. One in eight US women will mature mamma cancer in her lifetime pro plus overdose lasting effects. The disease is the understudy leading cancer killer of women in the country.
No comments:
Post a Comment